The client is on a blood thinner and is experiencing tinnitus. Which drug is the client likely taking?

Questions 52

ATI RN

ATI RN Test Bank

Drugs for Cardiovascular Disease Questions

Question 1 of 5

The client is on a blood thinner and is experiencing tinnitus. Which drug is the client likely taking?

Correct Answer: B

Rationale: In this scenario, the correct answer is B) Aspirin. Tinnitus, the perception of ringing in the ears, can be a side effect of aspirin, especially at higher doses. Aspirin is a common blood thinner used for its antiplatelet effects in cardiovascular disease. Option A) Pradaxa is a direct oral anticoagulant but is not typically associated with tinnitus as a side effect. Option C) Heparin is a different type of anticoagulant that is usually given intravenously or subcutaneously, and tinnitus is not a common side effect. Option D) Warfarin is an anticoagulant that can cause many side effects, but tinnitus is not a primary one. Educationally, understanding the side effects of medications is crucial for safe and effective patient care. By linking specific symptoms like tinnitus to certain drugs, healthcare providers can make informed decisions about medication management and potential adverse effects. This knowledge ensures patient safety and contributes to better overall outcomes in the management of cardiovascular diseases.

Question 2 of 5

An IRB-approved animal study involves injection of acetylcholine into the myocardium of a dog to study cardiac changes. Which of the following effects would likely be observed?

Correct Answer: A

Rationale: In an IRB-approved animal study involving the injection of acetylcholine into the myocardium of a dog, the likely effect observed would be a decreased cardiac output. Acetylcholine is a neurotransmitter that acts on muscarinic receptors in the heart, leading to a decrease in heart rate and contractility. The correct answer (A) is supported by the fact that acetylcholine, when acting on the heart, causes a negative inotropic effect, which decreases the force of contraction and subsequently reduces cardiac output. This is due to the activation of muscarinic receptors in the heart, which mediate parasympathetic effects. Option B, increased contractility, is incorrect because acetylcholine actually decreases contractility by inhibiting sympathetic activity. Option C, increased heart rate, is also incorrect because acetylcholine typically decreases heart rate by slowing down the firing of the sinoatrial node, the heart's natural pacemaker. Option D, increased stroke volume, is incorrect because acetylcholine's negative inotropic effect would lead to a decrease rather than an increase in stroke volume. From an educational standpoint, understanding the effects of neurotransmitters on the heart is crucial for healthcare professionals involved in the treatment of cardiovascular diseases. This knowledge helps in predicting how various drugs or interventions may impact cardiac function and aids in making informed clinical decisions.

Question 3 of 5

A 53-year-old woman with long-standing hypertension has already been treated with a ß-blocker and a calcium channel blocker, which have failed to control her blood pressure. She is now treated with losartan. Which of the following statements is correct regarding its pharmacokinetics?

Correct Answer: C

Rationale: Rationale: The correct answer is C) Extensive first-pass metabolism. Explanation: 1. **Why C is correct**: Losartan undergoes extensive first-pass metabolism in the liver by the enzyme CYP3A4 to its active metabolite, E-3174. This metabolite is responsible for most of the drug's effects on blood pressure regulation. 2. **Why others are wrong**: - A) Losartan is not converted to an inactive metabolite. Instead, it is converted to an active metabolite. - B) Losartan is primarily eliminated in the urine and feces, not via skin loss. - D) Losartan has a high binding affinity to plasma proteins, specifically albumin, which limits its distribution into tissues. Educational context: Understanding the pharmacokinetics of drugs used in cardiovascular diseases is crucial for healthcare providers to optimize treatment and manage potential drug interactions and adverse effects. Losartan's metabolism pathway highlights the importance of liver function in drug processing and the impact on therapeutic outcomes. This knowledge helps in making informed decisions for patient care and medication management.

Question 4 of 5

Alteplase:

Correct Answer: D

Rationale: Alteplase is a thrombolytic agent used in the treatment of conditions like acute myocardial infarction, stroke, and pulmonary embolism. The correct answer is D) Is indicated in the treatment of pulmonary embolism. Rationale: D) Alteplase is indicated in the treatment of pulmonary embolism because it works by converting plasminogen into plasmin, which helps dissolve blood clots. This action is crucial in conditions like pulmonary embolism where a blood clot blocks an artery in the lungs. A) Alteplase is not a prodrug that liberates streptokinase. It directly acts as a tissue plasminogen activator and does not require conversion into another form to be effective. B) Heparin can be administered concurrently with alteplase in some cases, especially in the treatment of acute myocardial infarction or ischemic stroke. The statement that heparin must not be administered within 24 hours of alteplase infusion is incorrect. C) Alteplase does not require pulmonary artery pressure measurement before administration. It is typically used based on clinical presentation and imaging findings in conditions like pulmonary embolism. Educational Context: Understanding the correct indications and contraindications of drugs used in cardiovascular diseases is critical for healthcare professionals. Alteplase is a potent thrombolytic agent with specific indications and protocols for use. Knowledge of these details ensures safe and effective patient care.

Question 5 of 5

Minoxidil is a potent arteriodilator acting by:

Correct Answer: C

Rationale: In the context of drugs for cardiovascular disease, understanding the mechanism of action of Minoxidil is crucial for healthcare professionals. Minoxidil is a potent arteriodilator that acts by opening potassium channels. This mechanism leads to hyperpolarization of vascular smooth muscle cells, causing relaxation and vasodilation of arterioles. Option A, blocking of calcium channels, is incorrect because Minoxidil does not affect calcium channels. Calcium channel blockers, on the other hand, work by inhibiting the influx of calcium ions into cells, leading to vasodilation. Option B, blocking of potassium channels, is also incorrect as Minoxidil actually opens potassium channels, leading to hyperpolarization and subsequent vasodilation. Option D, opening of chloride channels, is incorrect because Minoxidil's mechanism of action does not involve chloride channels. Educationally, understanding the specific mechanisms of action of cardiovascular drugs like Minoxidil is essential for healthcare professionals to make informed decisions in clinical practice. Knowing how a drug works allows for appropriate prescribing, monitoring for side effects, and understanding potential drug interactions. This knowledge ultimately contributes to better patient outcomes and safety.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions